Discovery of Imidazopyridine Derivatives as Highly Potent Respiratory Syncytial Virus Fusion Inhibitors-Reference-Cited by-同舟云学术

Discovery of Imidazopyridine Derivatives as Highly Potent Respiratory Syncytial Virus Fusion Inhibitors

Published:2015-01-28 Issue:3 Volume:6 Page:359-362
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Feng Song¹,Hong Di¹,Wang Baoxia¹,Zheng Xiufang¹,Miao Kun¹,Wang Lisha¹,Yun Hongying¹,Gao Lu¹,Zhao Shuhai¹,Shen Hong C.¹

Affiliation:

1. Medicinal Chemistry, ‡Molecular Design and Chemical Biology, and §Infectious Diseases, Pharmaceutical Research and Early Development, Roche Innovation Center Shanghai, Building 5, Lane 720, Cai Lun Road, Shanghai 201203, China

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.5b00008

Reference25 articles.

1. An Overview on Different Classes of Viral Entry and Respiratory Syncitial Virus (RSV) Fusion Inhibitors

2. Respiratory syncytial virus fusion inhibitors. Part 6: An examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety

3. Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years

4. Orally Active Fusion Inhibitor of Respiratory Syncytial Virus

5. Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. İMİDAZOPİRİDİN TÜREVLERİNİN KANSER HÜCRE SİNYALİNDEKİ ETKİLERİ;Kırıkkale Üniversitesi Tıp Fakültesi Dergisi;2024-08-20

2. C3-Alkylation of Imidazo[1,2-a]pyridines via Three-Component Aza-Friedel–Crafts Reaction Catalyzed by Y(OTf)3;Molecules;2024-07-24

3. Recent Progress toward the Discovery of Small Molecules as Novel Anti-Respiratory Syncytial Virus Agents;Journal of Medicinal Chemistry;2024-07-06

4. Microevolution and phylogenomic characterization of Respiratory Syncytial Virus Type A: An outlook of 2022-2023 outbreak;2024-03-04

5. Inhibition of respiratory syncytial virus by Daclatasvir and its derivatives: synthesis of computational derivatives as a new drug development;Journal of Biomolecular Structure and Dynamics;2024-01-13